Home > Insider Trading > Filing (0001181431-13-060956)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
822411	Immunocellular Therapeutics Ltd.	IMUC	Pharmaceutical Preparations (2834)	931301885

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1550545	S John Yu	23622 Calabasas Road, Suite 300 Calabasas CA 91302	Secretary	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-11-25	32,613	$0.25	42,613	No	4	M	Direct
Common Stock	Disposition	2013-11-25	32,613	$0.00	10,000	No	4	G	Direct
Common Stock	Acquisiton	2013-11-25	32,613	$0.00	32,613	No	4	G	Indirect	By Family Trust
Common Stock	Disposition	2013-10-18	32,613	$2.85	0	No	4	S	Indirect	By Family Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	G	Direct
No	4	G	Indirect	By Family Trust
No	4	S	Indirect	By Family Trust

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2013-11-25	32,613	$0.00	32,613	$0.25

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2014-02-25	No	4	M	Direct

Footnotes

These shares are being transferred to the reporting person's Family Trust.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported is an average price. The prices ranged from $2.8000 to $3.0300 per share. Full information regarding the number of shares sold at each separate price within the range set forth in this footnote is available upon request by the SEC, the issuer or a security holder of the issuer.
Fully vested.